Should factor v Leiden mutation and prothrombin gene polymorphism testing be done in women with recurrent miscarriage from North India?

Archives of Gynecology and Obstetrics

Volumn 287, Issue 2, 2013, Pages 375-381

  Parveen, Farah ^a   Shukla, Anju ^a   Agrawal, Suraksha ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Activated protein C and thrombophilia; Factor V Leiden (G1691A) mutation; Prothrombin gene (G20210A) polymorphism; Recurrent miscarriage; Thromboembolism

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; PROTHROMBIN;

ADULT; ARTICLE; BLOOD CLOTTING FACTOR 5 LEIDEN GENE; CASE CONTROL STUDY; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DNA POLYMORPHISM; FEMALE; GENE MUTATION; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HUMAN CELL; INDIA; MAJOR CLINICAL STUDY; META ANALYSIS; PROTHROMBIN GENE; SPONTANEOUS ABORTION;

ABORTION, HABITUAL; ADULT; CASE-CONTROL STUDIES; COST-BENEFIT ANALYSIS; DNA MUTATIONAL ANALYSIS; FACTOR V; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC MARKERS; GENETIC TESTING; GENOTYPING TECHNIQUES; HETEROZYGOTE; HUMANS; INDIA; POINT MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; PREGNANCY; PROTHROMBIN; RETROSPECTIVE STUDIES;

EID: 84878361105     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-012-2557-2     Document Type: Article

References (37)

1. Jaslow CR, Carney JL, Kutteh WH (2010) Diagnostic factors identified in 1020 women with two versus three or more recurrent pregnancy losses. Fertil Steril 93:1234-1243
2. Blumenfeld Z, Brenner B (1999) Thrombophilia-associated pregnancy wastage. Fertil Steril 72(5):765-774
3. Katz VL, Kuller JA (1994) Recurrent miscarriage. Am J Perinatol 11(6):386-397
4. Souleir J, Boffa M (1980) Avortements a repetition thromboses et anticoagulant circulant antithromboplastine: Trois observations. Nouv Presse Med 9:859
5. Amer L, Kisiel W, Searles RP, Williams RC Jr (1990) Impairment of the protein C anticoagulant pathway in a patient with systemic lupus erythematosus, anticardiolipin antibodies and thrombosis. Thromb Res 57(2):247-258
6. Branch DW, Silver RM, Blackwell JL, Reading JC, Scott JR (1992) Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience. Obstet Gynecol 80(4):614-620
7. Rossi E, Gatti L, Guarneri D, Finotto E, Lombardi A, Preda L (1992) Functional protein S in women with lupus anticoagulant inhibitor. Thromb Res 65(2):253-262
8. Braulke I, Pruggmayer M, Melloh P (1993) Factor XII (Hageman) deficiency in women with habitual abortions. New subpopulation of recurrent aborters? Fertil Steril 59:98-101
9. Girling J, de Sweit M (1998) Inherited thrombophilia and pregnancy. Curr Opin Obstet Gynecol 10:135-144
10. Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H et al (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369:64-67
11. Sottiltta G, Oriana V, Latella C, Luise F, Piromalli A, Ramirez F et al (2006) Genetic prothrombotic risk factors in women with unexplained pregnancy loss. Thromb Res 117:681-684
12. Pepe G, Rickards O, Vanegas OC, Brunelli T, Gori AM, Giusti B et al (1997) Prevalence of factor V Leiden mutation in non-European populations. Thromb Haemost 77(2):329-331
13. Baglin T, Gray E, Greaves M, Hunt BJ, Keeling D, Machin S et al (2010) Clinical guidelines for testing for heritable thrombophilia. Br J Haematol 149(2):209-220
14. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM (1996) A common genetic variation in the 3′ untranslated region of the prothrombin gene is associated with elevated prothrombin levels and an increase in venous thrombosis. Blood 88(10):3698-3703
15. Wallace BC, Schmid CH, Lau J, Trikalinos TA (2009) Meta-analyst: software for meta-analysis of binary, continuous and diagnostic data. BMC Med Res Methodol 4(9):80
16. Irani-Hakime N, Tamim H, Kreidy R, Almawi WY (2000) Prevalence of factor V R506Q - Leiden among apparently Lebanese patients. J Hematol 65(1):45-49
17. Geerts WH, Heit JA, Clagett GP, Pineo GF, Colwell CW, Anderson FA Jr et al (2001) Prevention of venous thromboembolism. Chest 119(1 Suppl):132S-175S (review)
18. Finan RR, Tamim H, Ameen G, Sharida HE, Rashid M, Almawi WY (2002) Prevalence of factor V G1691A (factor V-Leiden) and prothrombin G20210A gene mutations in a recurrent miscarriage population. Am J Hematol 71(4):300-305
19. Mohammad AM, Gamil Al-Halabi M, Monem FM (2007) Prevalence of factor V Leiden mutation and its relation with recurrent spontaneous pregnancy loss in a group of Syrian women. Middle East Fertil Soc J 12(3):179-183
20. Hossain N, Shamsi T, Khan N, Naz A (2012) Thrombophilia investigation in Pakistani women with recurrent pregnancy loss. J Obstet Gynaecol Res. doi: 10.1111/j.1447-0756.2012.01925.x
21. Pawar AR, Shetty S, Ghosh K, Mohanty D (2001) How old is factor V Leiden mutation? Thromb Haemost 86(6):1591-1592
22. Herrmann FH, Sanchez LS, Schroder W, Grimm R, Schuster G, Jimenez-arce G et al (2001) Prevalence of molecular risk factor FV Leiden, FVHR2, FII20210G→A and MTHFR 677C→T in different populations and ethnic groups of Germany, Costarica, and India. Int J Hum Genet 1:33-39
23. Rosendaal FR, Koster T, Vandenbroucke JP, Reitsma PH (1995) High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood 85(6):1504-1508
24. Mitraui N, Borgi L, Hizem S, Nsiri B, Finan RR, Gris JC et al (2005) Prevalence of antiphospholipid antibodies, factor V G1691A (Leiden) and prothrombin G20210A mutations in early and late recurrent pregnancy loss. Eur J Obstet Gynecol Reprod Biol 1119(2):164-170
25. Mahjoub T, Mtiraoui N, Tamim H, Hizem S, Finan RR, Nsiri B et al (2005) Association between adverse pregnancy outcomes and maternal factor V G1691A (Leiden) and prothrombin G20210A genotypes in women with a history of recurrent idiopathic miscarriages. Am J Hematol 80(1):12-19
26. Foka ZJ, Lambropoulos AF, Saravelos H, Karas GB, Karavida A, Agorastos T et al (2000) Factor V Leiden and prothrombin G20210A mutations, but not methylene tetrahydrofolate reductase C677T, are associated with recurrent miscarriages. Hum Reprod 15(2):458-462
27. Arruda VR, von Zuben PM, Soares MC, Menezes R, Annichino-Bizzacchi JM, Costa FF (1996) Very low incidence of Arg506→Gin mutation in the factor V gene among the Amazonian Indians and the Brazilian black population. Thromb Haemost 75(5):860-861
28. Zahed LF, Rayes RF, Mahfouz RA, Taher AT, Maarouf HH, Nassar AH (2006) Prevalence of factor V Leiden, prothrombin and methylene tetrahydrofolate reductase mutations in women with adverse pregnancy outcomes in Lebanon. Am J Obstet Gynecol 195(4):1114-1118
29. Alfirevic Z, Mousa HA, Martlew V, Briscoe L, Perez-Casal M, Toh CH (2001) Postnatal screening for thrombophilia in women with severe pregnancy complications. Obstet Gynecol 97(5 Pt 1):753-759
30. Carp H, Salomon O, Seidman D, Dardik R, Rosenberg N, Inbal A (2002) Prevalence of genetic markers for thrombophilia in recurrent pregnancy loss. Hum Reprod 17(6):1633-1637
31. Grandone E, Margaglione M, Colaizzo D, d'Addedda M, Cappucci G, Vecchione G et al (1997) Factor V Leiden is associated with repeated and recurrent unexplained fetal losses. Thromb Haemost 77(5):822-824
32. Rey E, Kahn SR, David M, Shrier I (2003) Thrombophilic disorders and fetal loss: a meta-analysis. Lancet 361(9361):901-908
33. Martinelli I, Taioli E, Cetin I, Marinoni A, Gerosa S, Villa MV et al (2000) Mutations in coagulation factors in women with unexplained late fetal loss. N Engl J Med 343(14):1015-1018
34. Pihusch R, Buchholz T, Lohse P, Rübsamen H, Rogenhofer N, Hasbargen U et al (2001) Thrombophilic gene mutations and recurrent spontaneous abortion: prothrombin mutation increases the risk in the first trimester. Am J Reprod Immunol 46(2):124-131
35. Kocher O, Cirovic C, Malynn E, Rowland CM, Bare LA, Young BA et al (2007) Obstetric complications in patients with hereditary thrombophilia identified using the LCx microparticle enzyme immunoassay: a controlled study of 5,000 patients. Am J Clin Pathol 127(1):68-75
36. Glueck CJ, Gogenini S, Munjal J, Tracy T, Pranikoff J, Wang P (2008) Factor V Leiden mutation: a treatable etiology for sporadic and recurrent pregnancy loss. Fertil Steril 89(2):410-416
37. Macik BG, Rand JH, Konkle BA (2001) Thrombophilia: what's a practitioner to do? Hematology Am Soc Hematol Educ Program 322-338